BMS-986090
BMS-986090 is a humanized monoclonal antibody antagonist targeting CD40. BMS-986090 is promising for research of autoimmune diseases such as systemic lupus erythematosus (SLE) and focal segmental glomerulosclerosis (FSGS) [1].
Product Specifications
UNSPSC
12352100
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]Rashmi P, et al. Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors. Ann Transl Med. 2023 Jun 30;11 (9) :315.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15160698 1 Vial
Lentiviral human KIAA1324 shRNA (UAS) - Lentiviral human KIAA1324 shRNA (UAS) (100)
Ask
View Details 
MBS6269972-01 0.1 mL
PDE4D3, NT (cAMP-specific 3',5'-cyclic Phosphodiesterase 4D, DPDE3, PDE43) (HRP)
Ask
View Details MBS6269972-02 5x 0.1 mL
PDE4D3, NT (cAMP-specific 3',5'-cyclic Phosphodiesterase 4D, DPDE3, PDE43) (HRP)
Ask
View Details